Interstitial lung disease Anti-drug antibodies Anti-interleukin-6 Antiphospholipid syndrome Aldostérone Machine learning B cell homeostasis Mass cytometry Fabry disease Middle Aged Aged Aldosterone Anticorps anti-agalsidase Inborn errors of metabolism Animals DM Antisynthetase Adverse drug reactions Autoantibodies Biomarker B-lymphocyte Antibodies Anti‐mitochondrial antibodies Antibody responses Biomarqueurs Myopathy Lysosomal storage diseases Amyotrophic lateral sclerosis Auto-immunité Autoimmune diseases Adjudication Amyotrophy Biomarkers Case reports Active Adolescence Systems biology IBM Autoimmunity COVID-19 Cardio-oncology Myositis and muscle disease Auto-antibodies Cytokines Acid-alpha-glucosidase Immune checkpoint inhibitors Analyses multidimensionnelles Multidisciplinarity Skeletal muscle Pharmacology Dependovirus/genetics/immunology Interferon Gene therapy Polymyositis Anémie hémolytique Female Male AAV vectors Immunotherapy Autoantibody Muscle Cancer Idiopathic inflammatory myopathies Antisynthetase syndrome Arthritis Adult AAV antibody Prognosis Anti-MDA5 autoantibodies Myositis Bioelectrical impedance analysis Dermatomyositis Acute Kidney Injury/epidemiology/etiology Inclusion body myositis Inflammation AAV vector Adeno-associated vector Data integration Humans Adeno-associated virus Assisted communication devices Abnormal movement Deep immune profiling Agalsidase Outcome measures Biopsy AAV Anti-synthetase syndrome Adeno-associated virus vector Anticorps spécifique des myosites Sphingosine-1-phosphate Anti-agalsidase antibodies Anti-IgE IgG Inflammatory myopathy AAV humoral immunity Antisynthétase Auto‐antibodies Myocarditis Anti-Mi2 IMNM